Sales Up 11%

Lonza Group (LONN.SW) said Wednesday that its sales in the first half climbed 11.2% year over year. The Swiss healthcare manufacturing company's sales were 3.37 billion francs, compared with 3.03 billion francs a year ago. At constant exchange rate, sales jumped 16%. For full-year 2026, the company reiterated its CER sales growth guidance between 11% and 12%.